Fertility preservation in malignancy and certain benign conditions is gaining momentum, with advancement in the techniques for the same. It has become more relevant with improving treatment of cancers and increasing life expectancy. Reproductive potential is an important aspect of a woman's life. It is the responsibility of the care provider to be aware of the options of fertility preservation. The various techniques available for the purpose of fertility preservation in females range from oocyte/embryo/ovarian tissue cryopreservation to fertility-preserving surgeries, and the choice of procedure depends on numerous patient and treatment factors. Healthcare provider must be able to assess eligibility of the patient for preservation of fertility potential, carefully balancing the risk and benefit of the same, in relation to the cancer treatment. There are other ethical and legal concerns, which must be discussed in detail with the woman. Therefore, counseling is an integral part of the process.
Woodruff TK. The oncofertility consortium – addressing fertility in young people with cancer. Nat Rev Clin Oncol 2010;7(8):466–475. DOI: 10.1038/nrclinonc.2010.81.
Wallace WH, Smith AG, Kelsey TW, et al. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol 2014;15(10):1129–1136. DOI: 10.1016/S1470-2045(14)70334-1.
Gidoni Y, Holzer H, Tulandi T, et al. Fertility preservation in patients with non-oncological conditions. Reprod Biomed Online 2008;16(6):792–800. DOI: 10.1016/S1472-6483(10)60144-7.
Goldman KN. Elective oocyte cryopreservation: an ounce of prevention? Fertil Steril 2018;109(6):1014–1015. DOI: 10.1016/j.fertnstert.2018.03.023.
Ethics Committee of the American Society for Reproductive Medicine. Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an ethics committee opinion. Fertil Steril 2018;110(6):1022–1028. DOI: 10.1016/j.fertnstert.2018.08.027.
Bedoschi G, Oktay K. Current approach to fertility preservation by embryo cryopreservation. Fertil Steril 2013;99(6):1496–1502. DOI: 10.1016/j.fertnstert.2013.03.020.
Tozzo P, Fassina A, Nespeca P, et al. Understanding social oocyte freezing in Italy: a scoping survey on university female students’ awareness and attitudes. Life Sciences, Soc Policy 2019;15(1):2–14.
Jones BPI, Saso S, Mania, Smith JR, et al. The dawn of a new ice age: social egg freezing. Acta Obstetricia et Gynecologica Scandinavica 2018;97(6):641–647. DOI: 10.1111/aogs.13335.
Donnez J, Dolmans MM. Ovarian tissue freezing: current status. Curr Opin Obstet Gynecol 2015;27(3):222–230. DOI: 10.1097/GCO.0000000000000171.
Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril 2014;101(5):1237–1243. DOI: 10.1016/j.fertnstert.2014.02.052.
Leonel ECR, Lucci CM, Amorim CA. Cryopreservation of human ovarian tissue: a review. Transfus Med Hemother 2019;46(3):173–181. DOI: 10.1159/000499054.
Salama M, Mallmann P. Emergency fertility preservation for female patients with cancer: clinical perspectives. Anticancer Res 2015;35(6):3117–3128.
Kumar P, Sharma A. Gonadotropin-releasing hormone analogs: understanding advantages and limitations. J Hum Reprod Sci 2014;7(3):170–174. DOI: 10.4103/0974-1208.142476.
